Immunovia Publishes Interim Report January-March 2022 ...Middle East

PR Newswire - News
STOCKHOLM, April 28, 2022 /PRNewswire/ -- January-March Net sales amounted to kSEK 182 (123) divided between sales of tests kSEK 122 (0) and royalties kSEK 60 (123) Net earnings amounted to MSEK -44 (-23) and earnings per share before and after dilution were SEK -1.95 (-1.04) Cash flow...

Read More Details
Finally We wish PressBee provided you with enough information of ( Immunovia Publishes Interim Report January-March 2022 )

Apple Storegoogle play

Also on site :